Stephen Squinto Net Worth & Insider Trades

Stephen Squinto - EVP, Alexion Pharmaceuticals Inc

As of October 28, 2014

What is Stephen Squinto's Net Worth?

The current estimated net worth of Alexion Pharmaceuticals Inc's EVP, Stephen Squinto, is estimated to be about $274.04M . Stephen Squinto owns about 106,508 units of Alexion Pharmaceuticals Inc common stock. In the last 11 years at Alexion Pharmaceuticals Inc, Stephen Squinto has sold an estimated value of $77.42M worth.

What is Stephen Squinto's Past Insider Trading?

Stephen Squinto's largest purchase order was 40,037 units , worth over $3.27M on October 30, 2013. Stephen Squinto's largest sale order was 101,683 units , worth over $10.91M on July 31, 2012. In total, Stephen Squinto has made about 73 transactions over 11 years of their time at Alexion Pharmaceuticals Inc. Stephen Squinto usually trades in January, with the busiest year in 2013. The most recent transaction was a sale order of 5,910 units , worth over $1.11M on October 28, 2014.

STEPHEN SQUINTO

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Stephen Squinto's' Mailing Address?

  • Mailing address is C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

What are Alexion Pharmaceuticals Inc's Past Insider Trades?

Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO .

ALEXION PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1